Thursday Afternoon Analyst Upgrades and Downgrades: Amazon, Bank of America, BioNTech, Chipotle, Disney and More

Thursday afternoon's analyst upgrades and downgrades included Amazon, Bank of America, BioNTech, Chipotle, Disney and more.

Published October 7, 2021, 4:02pm ET · 2 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© zoom-zoom / Getty Images

Markets climbed higher on Thursday after lawmakers in Washington reached an agreement to extend the government’s debt ceiling, preventing a shutdown. Many were calling for a default on the debt by mid-October. With this crisis firmly in the rearview, each of the major averages were up at least 1% on the day as equities across the board were charging higher.

24/7 Wall St. is reviewing some big analyst calls seen on Thursday. We have included the latest call on each stock, as well as a recent trading history and the consensus targets among analysts. Note that analyst calls seen earlier in the day were on AT&T, Alibaba, Box, Citrix, Five Below, Nio and more.

Amazon.com, Inc. (NASDAQ: AMZN | AMZN Price Prediction): Cowen reiterated an Outperform rating but cut the price target to $4,300. Shares were trading at around $3,304 on Thursday, and the analysts’ consensus target is $4,151.96.

Bank of America Corp. (NYSE: BAC): Wolfe Research downgrade3d to a Peer Perform rating from Outperform. Shares were trading near $44 on Wednesday, and the consensus price target is $44.13.

[nativounit]

BioNTech SE (NASDAQ: BNTX): Jefferies initiated coverage with a Hold rating and a $230 price target. Shares were last seen trading around $246. They have a consensus price target of $335.85.

Chipotle Mexican Grill, Inc. (NYSE: CMG): Wells Fargo reiterated an Overweight rating and raised the price target to $2,180 from $1,800. The shares have traded in a 52-week range of $1,172.29 to $1,958.55, while the current share price is near $1,846.

Horizon Therapeutics PLC (NASDAQ: HZNP): Jefferies resumed coverage with a Buy rating and a $132 price target. The consensus price target is $134.59, and the share price is roughly $113.

Sage Therapeutics, Inc. (NASDAQ: SAGE): Jefferies downgraded to a Hold rating from Buy and slashed the price target to $50 from $100. Shares were last seen trading near $45 apiece. The consensus price target is $81.37.

The Walt Disney Co. (NYSE: DIS): JPMorgan reiterated an Overweight rating and raised the price target to $230 from $220. The 52-week trading range is $117.23 to $203.02, and the share price is near $178.

Stock prices are very overextended, and it is not a question of if a large correction comes but when. So it makes sense for more conservative investors to pivot to a safer stance. See the five steps to take now.

Meme stock movers on Wednesday included Palantir and Workhorse. Cathie Wood’s ARK Invest bought a million shares of a mobile gaming platform provider.

[wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →